(R)-[11C]verapamil PET studies to assess changes in P-glycoprotein expression and functionality in rat blood-brain barrier after exposure to kainate-induced status epilepticus.
about
Workshop on Neurobiology of Epilepsy appraisal: new systemic imaging technologies to study the brain in experimental models of epilepsyPharmacokinetic modeling of P-glycoprotein function at the rat and human blood-brain barriers studied with (R)-[11C]verapamil positron emission tomography.Simultaneous Semimechanistic Population Analyses of Levofloxacin in Plasma, Lung, and Prostate To Describe the Influence of Efflux Transporters on Drug Distribution following Intravenous and Intratracheal Administration.Advances in PET imaging of P-glycoprotein function at the blood-brain barrier.PET and SPECT radiotracers to assess function and expression of ABC transporters in vivoImaging P-glycoprotein function in rats using [(11)C]-N-desmethyl-loperamide.Assessment of P-glycoprotein activity in the Blood-Brain Barrier (BBB) using Near Infrared Fluorescence (NIRF) imaging techniques.Alteration in P-glycoprotein functionality affects intrabrain distribution of quinidine more than brain entry-a study in rats subjected to status epilepticus by kainate.[11C]Flumazenil brain uptake is influenced by the blood-brain barrier efflux transporter P-glycoprotein.[11C]phenytoin revisited: synthesis by [11C]CO carbonylation and first evaluation as a P-gp tracer in rats.The impact of P-gp functionality on non-steady state relationships between CSF and brain extracellular fluid.
P2860
Q30580708-4026B24D-44B0-4D0F-B83B-60A13C0F727FQ36462753-12FCEAC2-4B66-44C6-ADAE-BF7534A1523CQ36571957-E5710BCC-8CB9-487C-867B-080F50DDC9F4Q36638627-C2A78E80-04C2-4E1A-837B-DE50EC606F7FQ36953090-35C64EBB-9C29-4D69-AA57-C1BEBE7DA020Q39437473-D8AFB026-5D7D-42E3-A35C-66F2E357B4E7Q39539362-58C42F55-922D-4B16-8B76-2C5377E266F3Q41249289-6967205E-C53B-4E48-B8A7-F8DC570B2158Q42153842-E575776C-6671-4B11-ACFD-42F6EA961734Q42354388-D6A296E0-4496-4043-82B7-BEBDC27518F8Q43069428-B13CA0BD-FAB1-4EFB-9FA5-4BC0161DD2AE
P2860
(R)-[11C]verapamil PET studies to assess changes in P-glycoprotein expression and functionality in rat blood-brain barrier after exposure to kainate-induced status epilepticus.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
(R)-[11C]verapamil PET studies ...... te-induced status epilepticus.
@ast
(R)-[11C]verapamil PET studies ...... te-induced status epilepticus.
@en
type
label
(R)-[11C]verapamil PET studies ...... te-induced status epilepticus.
@ast
(R)-[11C]verapamil PET studies ...... te-induced status epilepticus.
@en
prefLabel
(R)-[11C]verapamil PET studies ...... te-induced status epilepticus.
@ast
(R)-[11C]verapamil PET studies ...... te-induced status epilepticus.
@en
P2093
P2860
P50
P356
P1433
P1476
(R)-[11C]verapamil PET studies ...... te-induced status epilepticus.
@en
P2093
Carla F M Molthoff
Gert Luurtsema
Marc C Huisman
Rob A Voskuyl
P2860
P2888
P356
10.1186/1471-2342-11-1
P577
2011-01-03T00:00:00Z
P5875
P6179
1044756578